Received Aug 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV4 | HPV (GARDASIL) | MERCK & CO. INC. | 1 | — | — |
Patient had a dose of GARDASIL in JUN2014, and is a 24 year old female and wants to get the GARDASIL 9. She received the first dose at age 13. Pharmacist wasn't sure still whether to do a 2 or 3 dose schedule as it was a long interval of time since; No additional AE; This spontaneous report was received from a pharmacist and refers to a 24-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. In June 2014 at the age of 13 years, the patient was vaccinated with Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL), (Unknown by Reporter/one dose), (lot # and expiration date were not reported), for prophylaxis. Currently, the patient wanted to get the GARDASIL 9. The pharmacist was not sure still whether to do a 2 or 3 dose schedule as it was a long interval of time since the 1st dose and had concerns and was unsure (inappropriate schedule of product administration). No additional AE reported (no adverse event).